The in-licensing arm of an Asia-based pharma company with several US offices is seeking partnerships with companies based in the USA.
The firm seeks specialty biotech therapeutics in neurobiology, dermatology, respiratory, oncology and ophthalmology indications. The firm focuses on technology that are 2-3 years from the market and with a 505(b) (2) regulatory pathway. The firm will consider in-licensing and acquisitions in these specialty areas.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org